Goto

Collaborating Authors

 high-frequency oscillation


Benchmarking Smoothness and Reducing High-Frequency Oscillations in Continuous Control Policies

Christmann, Guilherme, Luo, Ying-Sheng, Mandala, Hanjaya, Chen, Wei-Chao

arXiv.org Artificial Intelligence

Reinforcement learning (RL) policies are prone to high-frequency oscillations, especially undesirable when deploying to hardware in the real-world. In this paper, we identify, categorize, and compare methods from the literature that aim to mitigate high-frequency oscillations in deep RL. We define two broad classes: loss regularization and architectural methods. At their core, these methods incentivize learning a smooth mapping, such that nearby states in the input space produce nearby actions in the output space. We present benchmarks in terms of policy performance and control smoothness on traditional RL environments from the Gymnasium and a complex manipulation task, as well as three robotics locomotion tasks that include deployment and evaluation with real-world hardware. Finally, we also propose hybrid methods that combine elements from both loss regularization and architectural methods. We find that the best-performing hybrid outperforms other methods, and improves control smoothness by 26.8% over the baseline, with a worst-case performance degradation of just 2.8%.


Integrating Artificial Intelligence with Real-time Intracranial EEG Monitoring to Automate Interictal Identification of Seizure Onset Zones in Focal Epilepsy

Varatharajah, Yogatheesan, Berry, Brent, Cimbalnik, Jan, Kremen, Vaclav, Van Gompel, Jamie, Stead, Matt, Brinkmann, Benjamin, Iyer, Ravishankar, Worrell, Gregory

arXiv.org Artificial Intelligence

An ability to map seizure-generating brain tissue, i.e., the seizure onset zone (SOZ), without recording actual seizures could reduce the duration of invasive EEG monitoring for patients with drug-resistant epilepsy. A widely-adopted practice in the literature is to compare the incidence (events/time) of putative pathological electrophysiological biomarkers associated with epileptic brain tissue with the SOZ determined from spontaneous seizures recorded with intracranial EEG, primarily using a single biomarker. Clinical translation of the previous efforts suffers from their inability to generalize across multiple patients because of (a) the inter-patient variability and (b) the temporal variability in the epileptogenic activity. Here, we report an artificial intelligence-based approach for combining multiple interictal electrophysiological biomarkers and their temporal characteristics as a way of accounting for the above barriers and show that it can reliably identify seizure onset zones in a study cohort of 82 patients who underwent evaluation for drug-resistant epilepsy. Our investigation provides evidence that utilizing the complementary information provided by multiple electrophysiological biomarkers and their temporal characteristics can significantly improve the localization potential compared to previously published single-biomarker incidence-based approaches, resulting in an average area under ROC curve (AUC) value of 0.73 in a cohort of 82 patients. Our results also suggest that recording durations between ninety minutes and two hours are sufficient to localize SOZs with accuracies that may prove clinically relevant. The successful validation of our approach on a large cohort of 82 patients warrants future investigation on the feasibility of utilizing intra-operative EEG monitoring and artificial intelligence to localize epileptogenic brain tissue.


The intrinsic value of HFO features as a biomarker of epileptic activity

Gliske, Stephen V., Moon, Kevin R., Stacey, William C., Hero, Alfred O. III

arXiv.org Machine Learning

High frequency oscillations (HFOs) are a promising biomarker of epileptic brain tissue and activity. HFOs additionally serve as a prototypical example of challenges in the analysis of discrete events in high-temporal resolution, intracranial EEG data. Two primary challenges are 1) dimensionality reduction, and 2) assessing feasibility of classification. Dimensionality reduction assumes that the data lie on a manifold with dimension less than that of the feature space. However, previous HFO analyses have assumed a linear manifold, global across time, space (i.e. recording electrode/channel), and individual patients. Instead, we assess both a) whether linear methods are appropriate and b) the consistency of the manifold across time, space, and patients. We also estimate bounds on the Bayes classification error to quantify the distinction between two classes of HFOs (those occurring during seizures and those occurring due to other processes). This analysis provides the foundation for future clinical use of HFO features and buides the analysis for other discrete events, such as individual action potentials or multi-unit activity.